European Companies Search Engine
EU funding (€3,890,065): Driving next generation autophagy researchers towards translation Hor10 Oct 2017 EU Research and Innovation programme "Horizon"
Text
Driving next generation autophagy researchers towards translation
The manipulation of autophagy has an enormous therapeutic potential to revolutionize the way we currently treat cancers, neurodegenerative disorders, inflammatory and infectious diseases. Despite the great promises made by pioneering medical studies, the still limited applied research on autophagy has hampered the translation of fundamental knowledge into clinical-grade products and improved healthcare. Applied autophagy research is essential to understand the roles of autophagy in the different physiological and pathological situations, to generate (disease) models and develop biomarkers and assays to assess its progress. The goal of the ETN Driving next generation autophagy researchers towards translation (DRIVE) is to train young scientists to fill this gap. DRIVE will equip its ESRs with an unique combination of knowledge and experimental expertise that are brought together in this consortium by the different partners. The realization of their projects in applied autophagy research will benefit of an exceptional interdisciplinary platform integrating cell biology, biochemistry, molecular biology, genetics, chemistry and “omics” approaches. In addition, DRIVE ESRs will acquire competencies to exploit the results for the development of products and techniques of commercial value. These ESRs will also be trained in disseminating results and knowledge through modern channels of communication.
Funded Companies:
| Company name | Funding amount |
| Centre National de la Recherche Scientifique CNRS | ? |
| Academisch Ziekenhuis Groningen | €510,749 |
| Adjuvatis | €262,876 |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | €495,746 |
| Anaxomics Biotech SL | €247,873 |
| Eberhard Karls Universitaet Tuebingen | €249,216 |
| Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. | €249,216 |
| Helsingin Yliopisto | €0.00 |
| Institute of Cancer Research: the Royal Cancer Hospital LBG | €273,288 |
| Institut National de la Sante et de la Recherche Medicale | €262,876 |
| King's College London | €273,288 |
| QPS Netherlands B.V. | €0.00 |
| Turun Yliopisto | €269,145 |
| Universitaetsklinikum Freiburg | €249,216 |
| Universitetet I Oslo | €286,275 |
| Weizmann Institute OF Science | €260,301 |
Source: https://cordis.europa.eu/project/id/765912
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Centre National de la Recherche Scientifique (CNRS) Autre établissement public national d'enseignement, Paris, France.
